Deal with $5.43 million greenshoe funds general corporate purposes
By Devika Patel
Knoxville, Tenn., May 31 - Endologix, Inc. has priced a $36.18 million public offering of stock with a $5.43 million greenshoe, according to a free-writing prospectus filed Thursday with the Securities and Exchange Commission. Piper Jaffray & Co. is the underwriter.
The company will sell 2.7 million common shares at $13.40 per share. The price per share reflects a 4.97% discount to the May 30 closing share price of $14.10.
Proceeds will be used for general corporate purposes.
Irvine, Calif.-based Endologix develops minimally invasive treatments for vascular diseases.
| Issuer: | Endologix, Inc.
|
| Issue: | Common stock
|
| Amount: | $36.18 million
|
| Greenshoe: | $5,427,000
|
| Units: | 2.7 million
|
| Price: | $13.40
|
| Warrants: | No
|
| Underwriter: | Piper Jaffray & Co.
|
| Pricing date: | May 31
|
| Stock symbol: | Nasdaq: ELGX
|
| Stock price: | $14.10 at close May 30
|
| Market capitalization: | $801.8 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
